| Product Code: ETC7924237 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a surge in import shipments of viral vectors and plasmid DNA, with top exporting countries including Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite the high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced significant growth with a remarkable CAGR of 43.42% from 2020 to 2024. However, there was a sharp decline in growth rate from 2023 to 2024, showing a decrease of -57.01%. This dynamic market landscape suggests both opportunities and challenges for stakeholders in the viral vectors and plasmid DNA import sector in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Viral Vectors and Plasmid DNA Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Viral Vectors and Plasmid DNA Market - Industry Life Cycle |
3.4 Latvia Viral Vectors and Plasmid DNA Market - Porter's Five Forces |
3.5 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Latvia Viral Vectors and Plasmid DNA Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing RD activities in the field of gene therapy and genetic engineering |
4.2.2 Growing investments in biotechnology and pharmaceutical industries |
4.2.3 Rising prevalence of genetic disorders and chronic diseases |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for gene therapy products |
4.3.2 High cost associated with research and development of viral vectors and plasmid DNA |
4.3.3 Limited availability of skilled professionals in gene therapy and biotechnology |
5 Latvia Viral Vectors and Plasmid DNA Market Trends |
6 Latvia Viral Vectors and Plasmid DNA Market, By Types |
6.1 Latvia Viral Vectors and Plasmid DNA Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Plasmid DNA, 2022 - 2032F |
6.1.4 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Vectors, 2022 - 2032F |
6.1.5 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Non-viral Vectors, 2022 - 2032F |
6.2 Latvia Viral Vectors and Plasmid DNA Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Cancers, 2022 - 2032F |
6.2.3 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Inherited Disorders, 2022 - 2032F |
6.2.4 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Infections, 2022 - 2032F |
6.2.5 Latvia Viral Vectors and Plasmid DNA Market Revenues & Volume, By Others, 2022 - 2032F |
7 Latvia Viral Vectors and Plasmid DNA Market Import-Export Trade Statistics |
7.1 Latvia Viral Vectors and Plasmid DNA Market Export to Major Countries |
7.2 Latvia Viral Vectors and Plasmid DNA Market Imports from Major Countries |
8 Latvia Viral Vectors and Plasmid DNA Market Key Performance Indicators |
8.1 Research funding allocated to gene therapy projects in Latvia |
8.2 Number of clinical trials involving viral vectors and plasmid DNA in Latvia |
8.3 Number of collaborations between academic institutions and biotech/pharma companies in gene therapy research |
9 Latvia Viral Vectors and Plasmid DNA Market - Opportunity Assessment |
9.1 Latvia Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Latvia Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Latvia Viral Vectors and Plasmid DNA Market - Competitive Landscape |
10.1 Latvia Viral Vectors and Plasmid DNA Market Revenue Share, By Companies, 2025 |
10.2 Latvia Viral Vectors and Plasmid DNA Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here